Article thumbnail

Monomeric and Dimeric CXCL8 Are Both Essential for In Vivo Neutrophil Recruitment

By Sandhya Thulasi Das, Lavanya Rajagopalan, Antonieta Guerrero-Plata, Jiqing Sai, Ann Richmond, Roberto P. Garofalo and Krishna Rajarathnam


Rapid mobilization of neutrophils from vasculature to the site of bacterial/viral infections and tissue injury is a critical step in successful resolution of inflammation. The chemokine CXCL8 plays a central role in recruiting neutrophils. A characteristic feature of CXCL8 is its ability to reversibly exist as both monomers and dimers, but whether both forms exist in vivo, and if so, the relevance of each form for in vivo function is not known. In this study, using a ‘trapped’ non-associating monomer and a non-dissociating dimer, we show that (i) wild type (WT) CXCL8 exists as both monomers and dimers, (ii) the in vivo recruitment profiles of the monomer, dimer, and WT are distinctly different, and (iii) the dimer is essential for initial robust recruitment and the WT is most active for sustained recruitment. Using a microfluidic device, we also observe that recruitment is not only dependent on the total amount of CXCL8 but also on the steepness of the gradient, and the gradients created by different CXCL8 variants elicit different neutrophil migratory responses. CXCL8 mediates its function by binding to CXCR2 receptor on neutrophils and glycosaminoglycans (GAGs) on endothelial cells. On the basis of our data, we propose that dynamic equilibrium between CXCL8 monomers and dimers and their differential binding to CXCR2 and GAGs mediates and regulates in vivo neutrophil recruitment. Our finding that both CXCL8 monomer and dimer are functional in vivo is novel, and indicates that the CXCL8 monomer-dimer equilibrium and neutrophil recruitment are intimately linked in health and disease

Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (1995). 1H NMR solution structure of an active monomeric interleukin-8.
  2. (2006). A homolog of the human chemokine receptor CXCR1 is expressed in the mouse.
  3. (1995). Activation of dual T cell signaling pathways by the chemokine RANTES.
  4. (2000). Bacterial clearance and survival are dependent on CXC chemokine receptor-2 ligands in a murine model of pulmonary Nocardia asteroides infection.
  5. (2003). Binding of interleukin-8 to heparan sulfate and chondroitin sulfate in lung tissue.
  6. (1995). Chemokine binding and activities mediated by the mouse IL-8 receptor.
  7. (2007). Chemokine signaling specificity: essential role for the N-terminal domain of chemokine receptors.
  8. (2008). Chemokines and their receptors: drug targets in immunity and inflammation.
  9. (2004). Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells.
  10. (2005). Cloning and characterization of mouse homolog of the CXC chemokine receptor CXCR1.
  11. (2009). CXCR2 antagonists for the treatment of pulmonary disease.
  12. (1994). Determination of the monomer-dimer equilibrium of interleukin-8 reveals it is a monomer at physiological concentrations.
  13. (2009). Differential activation and regulation of CXCR1 and CXCR2 by CXCL8 monomer and dimer.
  14. (2009). Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice.
  15. (2005). Effects of flow and diffusion on chemotaxis studies in a microfabricated gradient generator.
  16. (2005). Endothelial heparan sulfate deficiency impairs L-selectin- and chemokine-mediated neutrophil trafficking during inflammatory responses.
  17. (2003). Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines.
  18. (1999). Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses.
  19. (1997). Glycosaminoglycans mediate cell surface oligomerization of chemokines.
  20. (1994). High-resolution solution structure of the beta chemokine hMIP-1 beta by multidimensional NMR.
  21. (2008). How chemokines invite leukocytes to dance.
  22. (2001). Inducible expression of inflammatory chemokines in respiratory syncytial virusinfected mice: role of MIP-1alpha in lung pathology.
  23. (1993). Interleukin-8 antagonists generated by N-terminal modification.
  24. (2008). Interstitial leukocyte migration and immune function.
  25. (1991). Intravascular IL-8. Inhibitor of polymorphonuclear leukocyte accumulation at sites of acute inflammation.
  26. (2002). Leukocyte extravasation: chemokine transport and presentation by the endothelium.
  27. (2008). Macrophagespecific metalloelastase (MMP-12) truncates and inactivates ELR+CXC chemokines and generates CCL2, -7, -8, and -13 antagonists: potential role of the macrophage in terminating polymorphonuclear leukocyte influx.
  28. (2002). Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury.
  29. (2006). Migratory fate and differentiation of blood monocyte subsets.
  30. (2007). Murine CXCR1 is a functional receptor for GCP-2/CXCL6 and interleukin-8/ CXCL8.
  31. (1994). Neutrophil activation by monomeric interleukin-8.
  32. (1997). Neutrophil receptors for interleukin-8 and related CXC chemokines.
  33. (2006). Neutrophils and immunity: challenges and opportunities.
  34. (2006). Oligomerization of CXCL10 is necessary for endothelial cell presentation and in vivo activity.
  35. (2006). Probing receptor binding activity of interleukin-8 dimer using a disulfide trap.
  36. (1995). Proliferation of mature and immature subpopulations of bronchoalveolar monocytes/macrophages and peripheral blood monocytes.
  37. (1987). Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines.
  38. (2001). Ratio of local to systemic chemokine concentrations regulates neutrophil recruitment.
  39. (2005). Regulation of protein function by glycosaminoglycans–as exemplified by chemokines.
  40. (2009). Role of the chemokine receptor CXCR2 in bleomycin-induced pulmonary inflammation and fibrosis.
  41. (1993). Rot A
  42. (2008). Structural basis of CXCR4 sulfotyrosine recognition by the chemokine SDF-1/CXCL12.
  43. (2002). Structure, function, and inhibition of chemokines.
  44. (2008). T lymphocytes contribute to antiviral immunity and pathogenesis in experimental human metapneumovirus infection.
  45. (2009). The duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity.
  46. (2007). The human CC chemokine MIP-1beta dimer is not competent to bind to the CCR5 receptor.
  47. (1990). Three-dimensional structure of interleukin 8 in solution.
  48. (2002). Tissue-specific mechanisms control the retention of IL-8 in lungs and skin.